Body Vision Medical has received approval for its LungVision® imaging system in Australia, facilitating early lung cancer diagnosis using AI technology.

Contract awarded for products that bring improvement to healthcare industry CAMPBELL, Calif., July 9, 2024 /PRNewswire/ — Body Vision Medical announced its LungVision® AI-driven image guidance system has received an Innovative Technology contract from…

Body Vision Medical has received regulatory approval for its LungVision system in India, aiming to enhance lung cancer diagnosis through advanced AI imaging technology.

Body Vision Medical unveils a significant upgrade to its LungVision platform, enhancing accessibility to its AI Tomo® imaging technology for lung cancer diagnosis.

Body Vision Medical has achieved Pre-Market Approval for its AI-powered LungVision® platform in Singapore, enhancing early lung cancer diagnosis.

Body Vision Medical has successfully secured regulatory approval for its advanced LungVision imaging system in Brazil, enhancing lung cancer diagnosis using AI.

WALTHAM, Mass., Aug. 12, 2025 /PRNewswire/ -- Body Vision Medical, a leader in AI-powered intraoperative imaging, proudly announces a transformative upgrade to its LungVision platform: universal access to AI Tomo imaging. This achievement enables AI Tomo to be used with nearly any...

WALTHAM, Mass., Aug. 5, 2025 /PRNewswire/ -- Body Vision Medical, a leader in AI-powered intraoperative imaging, is pleased to announce that its LungVision advanced imaging platform has received Pre-Market Approval from Singapore's Health Sciences Authority (HSA). This clearance enables...

WALTHAM, Mass., July 29, 2025 /PRNewswire/ -- Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision advanced imaging system has received regulatory approval from ANVISA, Brazil's National Health Surveillance Agency. This...